Zhen Zhai

4.2k total citations · 2 hit papers
75 papers, 2.5k citations indexed

About

Zhen Zhai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhen Zhai has authored 75 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Zhen Zhai's work include Global Cancer Incidence and Screening (10 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (6 papers). Zhen Zhai is often cited by papers focused on Global Cancer Incidence and Screening (10 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (6 papers). Zhen Zhai collaborates with scholars based in China, United States and United Kingdom. Zhen Zhai's co-authors include Zhijun Dai, Yujiao Deng, Yi Zheng, Na Li, Linghui Zhou, Si Yang, Peng Xu, Dingli Song, Ying Wu and Qian Hao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Cancer.

In The Last Decade

Zhen Zhai

71 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017

2019 267 citations Na Li, Yujiao Deng et al. Journal of Hematology & Oncology profile →
Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019

2021 193 citations Yujiao Deng, Na Li et al. Frontiers in Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhen Zhai China	27	694	603	440	432	310	75	2.5k
Peng Xu China	24	489 0.7×	709 1.2×	412 0.9×	429 1.0×	228 0.7×	108	2.3k
Linghui Zhou China	29	976 1.4×	821 1.4×	433 1.0×	502 1.2×	212 0.7×	69	2.6k
Yujiao Deng China	32	822 1.2×	919 1.5×	550 1.3×	659 1.5×	345 1.1×	145	3.2k
Fulan Hu China	25	414 0.6×	554 0.9×	259 0.6×	324 0.8×	291 0.9×	127	2.2k
Lindsey Enewold United States	26	1.4k 2.0×	661 1.1×	546 1.2×	646 1.5×	394 1.3×	83	3.2k
Xiaochen Li China	21	508 0.7×	498 0.8×	687 1.6×	232 0.5×	176 0.6×	68	3.1k
Yi Zheng China	29	941 1.4×	1.2k 2.0×	695 1.6×	795 1.8×	433 1.4×	134	3.5k
Linda M. Liao United States	28	404 0.6×	671 1.1×	348 0.8×	315 0.7×	403 1.3×	106	2.6k
Sin Kam South Korea	28	495 0.7×	1.1k 1.9×	272 0.6×	382 0.9×	208 0.7×	116	2.5k

Countries citing papers authored by Zhen Zhai

Since Specialization

Citations

This map shows the geographic impact of Zhen Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Zhai more than expected).

Fields of papers citing papers by Zhen Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Zhai. The network helps show where Zhen Zhai may publish in the future.

Co-authorship network of co-authors of Zhen Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Zhai. A scholar is included among the top collaborators of Zhen Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Zhai. Zhen Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wanrong, Xue–Qian Li, Zhen Zhai, et al.. (2025). Epigenetic-targeted biomimetic nanomedicine modulates epithelial mesenchymal transition to enhance chemosensitivity in heterogeneous tumors. Biomaterials. 324. 123529–123529. 1 indexed citations

Liu, Ying, Zhen Zhai, Bo Wang, et al.. (2025). Eucommia folium can be Prepared as a Tea with the Ability to Prevent and Treat Hyperuricaemia. Plant Foods for Human Nutrition. 80(2). 92–92.

Li, Xinpei, Qing Li, Zhen Zhai, et al.. (2025). Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid. Cell Reports. 44(8). 116132–116132. 2 indexed citations

Wang, Meng, Yi Zheng, Qian Hao, et al.. (2025). Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis. Journal of Translational Medicine. 23(1). 39–39. 3 indexed citations

Zhai, Zhen, Dongsheng Zhu, Xin Zhong, et al.. (2024). Stachydrine represses the proliferation and enhances cell cycle arrest and apoptosis of breast cancer cells via PLA2G2A/DCN axis. Chemical Biology & Drug Design. 103(1). e14429–e14429. 8 indexed citations

Ren, Xueting, et al.. (2023). Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer. Frontiers in Immunology. 14. 1145552–1145552. 13 indexed citations

Zheng, Yi, Si Yang, Yujiao Deng, et al.. (2022). BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study. Clinical Breast Cancer. 22(5). e641–e646. 4 indexed citations

Wu, Ying, Yujiao Deng, Bajin Wei, et al.. (2022). Global, regional, and national childhood cancer burden, 1990–2019: An analysis based on the Global Burden of Disease Study 2019. Journal of Advanced Research. 40. 233–247. 68 indexed citations

Yang, Si, Bowen Yao, Liming Wu, et al.. (2021). Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma. Molecular Therapy — Oncolytics. 21. 207–219. 6 indexed citations

10.

Yang, Si, Shuai Lin, Kang Liu, et al.. (2021). Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer. Genomics. 113(2). 795–804. 11 indexed citations

11.

Deng, Yujiao, Na Li, Ying Wu, et al.. (2021). Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019. Frontiers in Endocrinology. 12. 672350–672350. 193 indexed citations breakdown →

12.

Deng, Yujiao, Bajin Wei, Zhen Zhai, et al.. (2021). Dietary Risk-Related Colorectal Cancer Burden: Estimates From 1990 to 2019. Frontiers in Nutrition. 8. 690663–690663. 48 indexed citations

13.

Xu, Peng, Jun Yao, Zhongrui Li, et al.. (2020). Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Zhou, Linghui, Shan‐Shan Dong, Yujiao Deng, et al.. (2019). GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis. Molecular Therapy — Nucleic Acids. 18. 56–65. 13 indexed citations

15.

Zhou, Linghui, Yujiao Deng, Na Li, et al.. (2019). Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study. Journal of Hematology & Oncology. 12(1). 107–107. 83 indexed citations

16.

Li, Yao, Linghui Zhou, Yujiao Deng, et al.. (2019). <p>Association Between Genetic Polymorphisms In <em>TYMS </em>And Glioma Risk In Chinese Patients: A Case-Control Study</p>. OncoTargets and Therapy. Volume 12. 8241–8247. 6 indexed citations

17.

Zhou, Linghui, Pengtao Yang, Yi Zheng, et al.. (2019). Effects of Postoperative Radiotherapy in Early Breast Cancer Patients Older than 75 Years: A Propensity-Matched Analysis. Journal of Cancer. 10(25). 6225–6232. 2 indexed citations

18.

Xue, Feng, Yi Zheng, Pengtao Yang, et al.. (2019). GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies. Cancer Cell International. 19(1). 76–76. 22 indexed citations

19.

Wang, Meng, Xinghan Liu, Shuai Lin, et al.. (2018). FABP1 Polymorphisms Contribute to Hepatocellular Carcinoma Susceptibility in Chinese Population with Liver Cirrhosis: A Case-Control Study. Journal of Cancer. 9(22). 4294–4300. 10 indexed citations

20.

Li, Daixi, Li Liu, Zhen Zhai, et al.. (2014). A molecular simulation study of the protection of insulin bioactive structure by trehalose. Journal of Molecular Modeling. 20(11). 2496–2496. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact